Crude membrane protein preparation from pooled prostate malignant carcinoma from China.
This antibody detects PMSA in prostate cancer but shows little or no cross-reactivity to benign prostate hyperplasia or to normal prostatic tissue.
Our Abpromise guarantee covers the use of ab19071 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|ELISA||Use at an assay dependent concentration.|
|WB||Use at an assay dependent concentration. Predicted molecular weight: 84 kDa.|
|IHC-P||Use at an assay dependent concentration.|
|IHC-Fr||Use at an assay dependent concentration.|
|ICC/IF||Use at an assay dependent concentration.|
|Flow Cyt||Use 0.1µg for 106 cells. ab170192-Mouse monoclonal IgG2b, is suitable for use as an isotype control with this antibody.|
Immunohistochemistry of formalin-fixed paraffin embedded prostate cancer tissue sections labeling PSMA with ab19071 at 1:1000 dilution.